Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

Transfusion

Volumn 47, Issue 10, 2007, Pages 1851-1857

  Lefrère, François ^a   Zohar, Sarah ^b   Beaudier, Sandrine ^b   Audat, Françoise ^b   Ribeil, Jean Antoine ^b   Ghez, David ^b   Varet, Bruno ^b   Cavazzana Calvo, Marina ^b   Cortivo, Liliane Dal ^b   Letestu, Rémi ^b   McIntyre, Elizabeth ^b   Brouzes, Chantal ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ALGORITHM; ANALYZER; APHERESIS; ARTICLE; BLOOD VOLUME; CELL COUNT; CELL MOTILITY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; ANTIGENS, CD; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LYMPHOMA; MIDDLE AGED; NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 34548769324     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01407.x     Document Type: Article

References (23)

1. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger D. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988 71 : 723 7.
2. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG. Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993 81 : 2031 5.
3. Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, Radford JA, Salles G, Schmitz N, Symann M, Armitage JO, Philip T, Coiffier B. International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol 1999 17 : 423 9.
4. Kroschinsky F, Holig K, Platzbecker U, Poppe-Thiede K, Ordemann R, Blechschmidt M, Oelschlaegel U, Schaich M, Hanel M, Bornhauser M, Ehninger G. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma. Transfusion 2006 46 : 1417 23.
5. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 2006 46 : 1934 42.
6. Lefrère F, Levy V, Makke J, Audat F, Cavazzana-Calvo M, Miclea JM. Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure. Haematologica 2004 89 : 1532 4.
7. Endo T, Sato N, Mogi Y, Koizumi K, Nishio M, Fujimoto K, Sakai T, Kumano K, Obara M, Ikeda H, Koike T. Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 2004 33 : 703 7.
8. Moncada V, Bolan C, Yau YY, Leitman SF. Analysis of PBPC cell yields during large-Volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 2003 43 : 495 501.
9. Meehan KR, Hill JM, Patchett L, Webber SM, Wu J, Ely P, Szczepiorkowski ZM. Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization. Transfusion 2006 46 : 523 9.
10. Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999 39 : 442 50.
11. Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Bonadonna G, Gianni M. Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation. comparative analysis of different CD34 monoclonal antibodies. Haematologica 1991 76 : 330 3.
12. Boccadoro M, Palumbo A, Bringhen S, Merletti F, Ciccone G, Richiardi L, Rus C, Bertola A, Giaccone L, Omede P, Musto P. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma. Haematologica 2002 87 : 846 50.
13. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995 13 : 2547 55.
14. Lefrere F, Audat F, Hermine O, Cavazzana-Calvo M, Belanger C, Arnulf B, Buzyn A, Varet B. The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases. Transfusion 1999 39 : 561 4.
15. YuJ, Leisenring W, Fritschle W, Heimfeld S, Shulman H, Bensinger WI, Holmberg LA, Rowley SD. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000 25 : 1157 64.
16. Suh C, Kim S, Kim SH, Kim EK, Lee JL, Park KU, Park JS, Lee J, Kim MW, Chi HS, Park CJ, Kim SW. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000. Transfusion 2004 44 : 1762 8.
17. Vogel W, Kopp HG, Kanz L, Einsele H. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens. J Cancer Res Clin Oncol 2002 128 : 380 4.
18. Pollard Y, Watts MJ, Grant D, Chavda N, Linch DC, Machin SJ. Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol 1999 106 : 538 44.
19. Abrahamsen JF, Stamnesfet S, Liseth K, Hervig T, Bruserud O. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion 2005 45 : 248 53.
20. Lefrere F, Makki J, Marolleau JP, Cortivo LD, Alberti C, Benbunan M, Miclea JM. CD34+ cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected. Transfusion 2000 40 : 493 5.
21. Lefrere F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients. Bone Marrow Transplant 2006 37 : 725 9.
22. Malerba L, Mele A, Leopardi G, Stramigioli S, Politi P, Visani G. Pelfigrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient. Eur J Haematol 2006 76 : 436 9.
23. Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballester O, Tarantolo S, Stiff P, Kuhn D, Scherzo E, Sing A, Jacobs C, White JM, DiPersio J. Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells. Bone Marrow Transplant 1999 24 : 25 8.